These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32524994)

  • 21. Protective Features of Calorie Restriction on Cuprizone-induced Demyelination via Modulating Microglial Phenotype.
    Zarini D; Pasbakhsh P; Nekoonam S; Mojaverrostami S; Ghasemi S; Shabani M; Kashani IR
    J Chem Neuroanat; 2021 Oct; 116():102013. PubMed ID: 34391881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different Methods for Evaluating Microglial Activation Using Anti-Ionized Calcium-Binding Adaptor Protein-1 Immunohistochemistry in the Cuprizone Model.
    Wittekindt M; Kaddatz H; Joost S; Staffeld A; Bitar Y; Kipp M; Frintrop L
    Cells; 2022 May; 11(11):. PubMed ID: 35681418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination.
    Acs P; Komoly S
    Ideggyogy Sz; 2012 Jul; 65(7-8):266-70. PubMed ID: 23074847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lesion Expansion in Experimental Demyelination Animal Models and Multiple Sclerosis Lesions.
    Große-Veldmann R; Becker B; Amor S; van der Valk P; Beyer C; Kipp M
    Mol Neurobiol; 2016 Sep; 53(7):4905-17. PubMed ID: 26363796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anatomical Distribution of Cuprizone-Induced Lesions in C57BL6 Mice.
    Goldberg J; Clarner T; Beyer C; Kipp M
    J Mol Neurosci; 2015 Oct; 57(2):166-75. PubMed ID: 26067430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination.
    Mullin AP; Cui C; Wang Y; Wang J; Troy E; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
    Neurobiol Dis; 2017 Sep; 105():142-155. PubMed ID: 28576706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxicity of cuprizone a Cu(2+) chelating agent on isolated mouse brain mitochondria: a justification for demyelination and subsequent behavioral dysfunction.
    Faizi M; Salimi A; Seydi E; Naserzadeh P; Kouhnavard M; Rahimi A; Pourahmad J
    Toxicol Mech Methods; 2016 May; 26(4):276-83. PubMed ID: 27088566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. De- and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected.
    Skripuletz T; Gudi V; Hackstette D; Stangel M
    Histol Histopathol; 2011 Dec; 26(12):1585-97. PubMed ID: 21972097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The hippocampal fimbria of cuprizone-treated animals as a structure for studying neuroprotection in multiple sclerosis.
    Kipp M; Norkus A; Krauspe B; Clarner T; Berger K; van der Valk P; Amor S; Beyer C
    Inflamm Res; 2011 Aug; 60(8):723-6. PubMed ID: 21516513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regional heterogeneity of cuprizone-induced demyelination: topographical aspects of the midline of the corpus callosum.
    Schmidt T; Awad H; Slowik A; Beyer C; Kipp M; Clarner T
    J Mol Neurosci; 2013 Jan; 49(1):80-8. PubMed ID: 23054589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory demyelination alters subcortical visual circuits.
    Araújo SES; Mendonça HR; Wheeler NA; Campello-Costa P; Jacobs KM; Gomes FCA; Fox MA; Fuss B
    J Neuroinflammation; 2017 Aug; 14(1):162. PubMed ID: 28821276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cuprizone induces similar demyelination in male and female C57BL/6 mice and results in disruption of the estrous cycle.
    Taylor LC; Gilmore W; Ting JP; Matsushima GK
    J Neurosci Res; 2010 Feb; 88(2):391-402. PubMed ID: 19746424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ellagic acid improves muscle dysfunction in cuprizone-induced demyelinated mice via mitochondrial Sirt3 regulation.
    Khodaei F; Rashedinia M; Heidari R; Rezaei M; Khoshnoud MJ
    Life Sci; 2019 Nov; 237():116954. PubMed ID: 31610192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional antagonism of sphingosine-1-phosphate receptor 1 prevents cuprizone-induced demyelination.
    Kim S; Bielawski J; Yang H; Kong Y; Zhou B; Li J
    Glia; 2018 Mar; 66(3):654-669. PubMed ID: 29193293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cuprizone model: regional heterogeneity of pathology.
    Wergeland S; Torkildsen Ø; Myhr KM; Mørk SJ; Bø L
    APMIS; 2012 Aug; 120(8):648-57. PubMed ID: 22779688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced cuprizone-induced cerebellar demyelination in mice with astrocyte-targeted production of IL-6 is associated with chronically activated, but less responsive microglia.
    Petković F; Campbell IL; Gonzalez B; Castellano B
    J Neuroimmunol; 2017 Sep; 310():97-102. PubMed ID: 28778453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of Translocator Protein and [18F]-GE180 Ligand Uptake in Multiple Sclerosis Animal Models.
    Nack A; Brendel M; Nedelcu J; Daerr M; Nyamoya S; Beyer C; Focke C; Deussing M; Hoornaert C; Ponsaerts P; Schmitz C; Bartenstein P; Rominger A; Kipp M
    Cells; 2019 Jan; 8(2):. PubMed ID: 30696113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination.
    Tomas-Roig J; Wirths O; Salinas-Riester G; Havemann-Reinecke U
    CNS Neurosci Ther; 2016 May; 22(5):387-95. PubMed ID: 26842941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostaglandin F2α FP receptor inhibitor reduces demyelination and motor dysfunction in a cuprizone-induced multiple sclerosis mouse model.
    Iwasa K; Yamamoto S; Takahashi M; Suzuki S; Yagishita S; Awaji T; Maruyama K; Yoshikawa K
    Prostaglandins Leukot Essent Fatty Acids; 2014 Nov; 91(5):175-82. PubMed ID: 25224839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-17-induced Act1-mediated signaling is critical for cuprizone-induced demyelination.
    Kang Z; Liu L; Spangler R; Spear C; Wang C; Gulen MF; Veenstra M; Ouyang W; Ransohoff RM; Li X
    J Neurosci; 2012 Jun; 32(24):8284-92. PubMed ID: 22699909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.